Venous access

CHF Solutions Submits Patent Application for New Peripheral Venous Access Technology for Ultrafiltration and CRRT Systems

Retrieved on: 
Thursday, March 11, 2021
Medical equipment, Venous access, Ultrafiltration, Medicine, Branches of biology, Catheters, Biology, Membrane technology, Intravenous fluids

The new system is intended to make CRRT therapies available to all patients through simple, safe, and easy-to-use peripheral venous access.

Key Points: 
  • The new system is intended to make CRRT therapies available to all patients through simple, safe, and easy-to-use peripheral venous access.
  • Aquadex SmartFlow currently provides ultrafiltration therapy through either central or peripheral venous access.
  • Access to innovative care solutions for patients with cardio-kidney disease is our priority at CHF Solutions, saidNestor Jaramillo, Jr., President and CEO ofCHF Solutions.
  • Ease of use and specifically, the option for peripheral venous access, removes burdens for clinicians to put patients on ultrafiltration therapies.

Access Vascular, Inc. Secures $20 Million in Series B Financing

Retrieved on: 
Wednesday, March 3, 2021
Biotechnology, Health, Medical devices, Medical equipment, Venous access, Vascular access, Access Vascular, TVM Capital Life Science

Access Vascular, Inc. , a company addressing the most common and costly venous access complications, today announced it has closed on a Series B round of financing.

Key Points: 
  • Access Vascular, Inc. , a company addressing the most common and costly venous access complications, today announced it has closed on a Series B round of financing.
  • TVM Capital Life Science led the round with a $15 million commitment, with existing investors also participating.
  • Their commitment to partnering with Access Vascular validates our conviction to continue solving critical issues in the vascular access space with our growing portfolio of proprietary technologies.
  • We believe that Access Vasculars products can address the biggest unmet needs in the vascular access space.

HydroMID Midline Catheter from Access Vascular Receives FDA Clearance

Retrieved on: 
Thursday, February 11, 2021
General Health, FDA, Medical devices, Other Health, Health, Catheters, Medical equipment, Medicine, Venous access, Vascular access, Port, Central venous catheter, ICU Medical

today announced FDA clearance of its HydroMID midline catheter.

Key Points: 
  • today announced FDA clearance of its HydroMID midline catheter.
  • HydroMID will be made available over the next few weeks to gain clinical feedback on the usage of this midline catheter.
  • FDA clearance for our second device demonstrates our commitment to a full product portfolio of venous access solutions and our commitment to help clinicians address the thrombus accumulation and catheter occlusion complications plaguing patients, said Access Vascular CEO James Biggins.
  • The use of midline catheters in the adult acute care setting clinical implications and recommendations for practice; Journal of the Association for Vascular Access.

CHF Solutions Protects New Peripheral Vascular Access Catheter with Patent Application

Retrieved on: 
Tuesday, January 12, 2021
Catheters, Vascular access, Venous access, Central venous catheter, Dialysis catheter

EDEN PRAIRIE, Minn., Jan. 12, 2021 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced the submission of a patent application for a peripheral vascular access catheter for use with its Aquadex system.

Key Points: 
  • EDEN PRAIRIE, Minn., Jan. 12, 2021 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced the submission of a patent application for a peripheral vascular access catheter for use with its Aquadex system.
  • The new dual lumen ultrafiltration catheter optimizes blood flow, prevents kinking, and is customizable for each patient, eliminating the need for multiple catheter sizes.
  • A key advantage of the Aquadex system is its ability to provide venous access in the patients arm rather than the common and less comfortable central vein access.
  • Blood flow optimization is an important element of effective ultrafiltration therapy and the catheter designs in this patent application will help elevate the precision clinicians have grown to love with Aquadex, said John Erb, CEO of CHF Solutions.

Global Central Venous Catheters Market Analysis and Forecast Model - COVID-19 Market Impacts - ResearchAndMarkets.com

Retrieved on: 
Thursday, January 7, 2021
Medical devices, Health, Catheters, Central venous catheter, Peripheral venous catheter, Venous access

The "Central Venous Catheters (Drug Delivery Devices) - Global Market Analysis and Forecast Model (COVID-19 market impact)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Central Venous Catheters (Drug Delivery Devices) - Global Market Analysis and Forecast Model (COVID-19 market impact)" report has been added to ResearchAndMarkets.com's offering.
  • Central Venous Catheters (Drug Delivery Devices) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within Drug Delivery Devices therapeutic area.
  • The model discusses in detail the impact of COVID-19 on Central Venous Catheters market for the year 2020 and beyond.
  • Track device sales in the global and country-specific Central Venous Catheters market from 2015-2030.

United States Central Venous Catheter Market Report 2020-2026 with COVID-19 Impact - ResearchAndMarkets.com

Retrieved on: 
Wednesday, November 11, 2020
Medical Supplies, Health, Catheters, Central venous catheter, CVC, Peripheral venous catheter, Market segmentation, Vascular access for chemotherapy, Venous access

The "Central Venous Catheter Market Report with COVID Impact - United States - 2020-2026 - MedCore" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Central Venous Catheter Market Report with COVID Impact - United States - 2020-2026 - MedCore" report has been added to ResearchAndMarkets.com's offering.
  • This MedCore report focuses on the Central Venous Catheters market segment and provides detailed analysis on the Market Size, Unit Sales, ASPs, and Company Market Shares.
  • The total U.S. market for central venous catheters (CVCs) comprises acute CVCs and chronic CVCs.
  • The largest CVC segment in 2019 was the acute CVC segment, which represented the vast majority of the total CVC market.

2020 Hemodialysis Catheters Pipeline Insight and Competitive Landscape: Comprehensive Insights on 15 Companies & Drug Profiles - ResearchAndMarkets.com

Retrieved on: 
Tuesday, October 20, 2020
Retail, Other Retail, Catheters, Medicine, Clinical medicine, Medical equipment, Membrane technology, Renal dialysis, Venous access, Hemodialysis, Dialysis catheter, Peripheral venous catheter, Dialysis, Port

The "Hemodialysis Catheters Pipeline Insight and Competitive Landscape, 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Hemodialysis Catheters Pipeline Insight and Competitive Landscape, 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • The "Hemodialysis Catheters - Pipeline Insight and Competitive Landscape, 2020," report provides comprehensive insights about 15+ companies and 15+ pipeline devices in Hemodialysis Catheters pipeline landscape.
  • 15+ key companies which are developing the products for Hemodialysis Catheters.
  • Access Vascular is developing a comprehensive suite of venous access devices, including peripheral venous catheters, dialysis catheter and ports.

Global Central Venous Catheter Market to Surpass US$ 3,060.3 Million by 2027, Says Coherent Market Insights (CMI)

Retrieved on: 
Thursday, September 17, 2020
General Health, Consulting, Medical devices, Health, Professional services, Catheters, Central venous catheter, Venous access, Peripheral venous catheter, Vascular access for chemotherapy, Groshong line

According to Coherent Market Insights, the Global Central Venous Catheter Market is estimated to be valued at US$ 2,002.2 million in 2020 and is expected to exhibit a CAGR of 6.2% during the forecast period (2020-2027).

Key Points: 
  • According to Coherent Market Insights, the Global Central Venous Catheter Market is estimated to be valued at US$ 2,002.2 million in 2020 and is expected to exhibit a CAGR of 6.2% during the forecast period (2020-2027).
  • Key Trends and Analysis of the Global Central Venous Catheter Market:
    Increasing number of approvals and launch of novel catheters is expected to fuel growth of the global central venous catheter market.
  • North America central venous catheter market is expected to hold dominant position in the global central venous catheter market during the forecast period owing to an increasing number of product launches and approvals of central venous catheters.
  • The system is developed to obtain central venous access for catheter insertion in central venous system for patients suffering from upper body venous occlusions.

Citius Announces Expanded Access Program for Investigational Phase 3 Mino-Lok®

Retrieved on: 
Tuesday, May 26, 2020
Medicine, Catheters, Clinical medicine, Central venous catheter, Venous access, Peripheral venous catheter, Hemodialysis, Bacteremia, Dialysis, Vascular access for chemotherapy, Vascular access

Through the Expanded Access protocol, an infected central venous catheter can now be treated with Citius' Mino-Lok, potentially avoiding the need for the removal and replacement procedure.

Key Points: 
  • Through the Expanded Access protocol, an infected central venous catheter can now be treated with Citius' Mino-Lok, potentially avoiding the need for the removal and replacement procedure.
  • Given the challenges at today's hospitals, the patients, the hospital staff, and the hospital system at large stand to benefit greatly from free access to the Mino-Lok solution.
  • Mino-Lok is currently in a Phase 3 clinical trial for the treatment of central line-associated bloodstream infections (CLABSIs).
  • CLABSIs/CRBSIsare very serious, especially in cancer patients receiving therapy through central venous catheters (CVCs) and in hemodialysis patients, for whom venous access presents a challenge.

Teleflex awarded Central Venous Access, Arterial Access agreements with Premier

Retrieved on: 
Wednesday, April 29, 2020
Medical equipment, Venous access, Vascular access, Teleflex, Catheter

WAYNE, Pa., April 29, 2020 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, has been awarded group purchasing agreements for Central Venous Access and Arterial Access with Premier, effective July 1.

Key Points: 
  • WAYNE, Pa., April 29, 2020 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, has been awarded group purchasing agreements for Central Venous Access and Arterial Access with Premier, effective July 1.
  • Premier has awarded Teleflex a multi-source Central Venous Access Product and sole source Arterial Catheter agreement for National members.
  • These new agreements allow Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for CVC and Arterial Vascular Access Products.
  • As the market leader in CVCs and Arterial devices1-2, we are pleased to offer Premier members one of the broadest portfolios of central access and arterial access products available.